We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical (EMN) to Post Q3 Earnings: What's in Store?
Read MoreHide Full Article
Eastman Chemical Company (EMN - Free Report) is scheduled to release third-quarter 2023 results after the closing bell on Oct 26.
The company surpassed Zacks Consensus Estimate for earnings in three of the last four quarters while missing it once. It delivered a trailing four-quarter earnings surprise of around 2.2% on average. It pulled off an earnings surprise of 2.1% in the last reported quarter.
Eastman is expected to have benefited from cost-cutting and productivity initiatives, as well as its innovation-driven growth strategy. However, headwinds, including lower demand and customer de-stocking, are likely to have weighed on its third-quarter performance.
The stock has lost 6.7% in the past year in line with industry’s fall of 6.7%.
Image Source: Zacks Investment Research
What Do the Estimates Say?
The Zacks Consensus Estimate for sales for the to-be-reported quarter is currently pegged at $2,260.8 million, which implies a decline of 16.6% from the year-ago reported number.
Our estimate for EMN’s Additives and Functional Products division’s revenues is pegged at $736.1 million, suggesting a fall of 18.8% year over year. The same for the Advanced Materials unit’s revenues is $741.5 million, indicating a decline of 16.5%.
Our estimate for Eastman’s Chemical Intermediates segment’s revenues is pegged at $470.5 million, suggesting a decline of 29.3%. The same for Fiber Segment stands at $318.1 million, indicating an increase of 27.3% year over year.
Some Factors to Watch
Eastman is expected to have benefited from its cost-cutting measures. The company's operational transformation effort is likely to have resulted in decreased operating costs in the third quarter. It is on target to save more than $200 million in production, supply chain and non-manufacturing costs by 2023, net of inflation. Lower raw material and energy costs, as well as pricing actions, are likely to have aided the company's bottom line.
The company’s performance is likely to have been supported by efforts to generate new business revenues from its innovative growth model. Its innovation and market development initiatives are expected to have aided sales volumes in the quarter.
Eastman Chemical's performance is likely to have been hurt by the lingering impacts of customer inventory de-stocking. In the second quarter of 2023, the company saw lackluster demand and customer de-stocking in its consumer durables, building & construction, consumables and agriculture end markets. De-stocking is likely to have had an impact on the company's volumes and top line in the third quarter as well.
The company, in July 2023, reduced its demand growth prediction and now anticipates primary demand in several of its end markets to be flat in the second half compared to the first. It also anticipates that customer de-stocking will continue. EMN expects adjusted earnings per share to be lower in the second half of 2023 than in the first half.
Zacks Model
Our proven model does not conclusively predict an earnings beat for Eastman Chemical this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for Eastman Chemical is -2.59%. This is because the Most Accurate Estimate is currently pegged at $1.41 while the Zacks Consensus Estimate stands at $1.45. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Eastman Chemical currently carries a Zacks Rank #3.
Here are some companies in the basic materials space you may want to consider, as our model shows these have the right combination of elements to post an earnings beat this quarter:
The Zacks Consensus Estimate for earnings for KGC for the third quarter is pegged at 9 cents.
LyondellBasell Industries N.V. (LYB - Free Report) , scheduled to release earnings on Oct 27, has an Earnings ESP of +5.14% and carries a Zacks Rank #3.
The consensus estimate for LYB’s earnings for the third quarter is currently pegged at $1.98.
IAMGOLD Corporation (IAG - Free Report) , which is scheduled to release earnings on Nov 9, has an Earnings ESP of +100.00% and carries a Zacks Rank #1.
The consensus estimate for IAG for the third quarter is currently pegged at a loss of 2 cents.
Image: Bigstock
Eastman Chemical (EMN) to Post Q3 Earnings: What's in Store?
Eastman Chemical Company (EMN - Free Report) is scheduled to release third-quarter 2023 results after the closing bell on Oct 26.
The company surpassed Zacks Consensus Estimate for earnings in three of the last four quarters while missing it once. It delivered a trailing four-quarter earnings surprise of around 2.2% on average. It pulled off an earnings surprise of 2.1% in the last reported quarter.
Eastman is expected to have benefited from cost-cutting and productivity initiatives, as well as its innovation-driven growth strategy. However, headwinds, including lower demand and customer de-stocking, are likely to have weighed on its third-quarter performance.
The stock has lost 6.7% in the past year in line with industry’s fall of 6.7%.
Image Source: Zacks Investment Research
What Do the Estimates Say?
The Zacks Consensus Estimate for sales for the to-be-reported quarter is currently pegged at $2,260.8 million, which implies a decline of 16.6% from the year-ago reported number.
Our estimate for EMN’s Additives and Functional Products division’s revenues is pegged at $736.1 million, suggesting a fall of 18.8% year over year. The same for the Advanced Materials unit’s revenues is $741.5 million, indicating a decline of 16.5%.
Our estimate for Eastman’s Chemical Intermediates segment’s revenues is pegged at $470.5 million, suggesting a decline of 29.3%. The same for Fiber Segment stands at $318.1 million, indicating an increase of 27.3% year over year.
Some Factors to Watch
Eastman is expected to have benefited from its cost-cutting measures. The company's operational transformation effort is likely to have resulted in decreased operating costs in the third quarter. It is on target to save more than $200 million in production, supply chain and non-manufacturing costs by 2023, net of inflation. Lower raw material and energy costs, as well as pricing actions, are likely to have aided the company's bottom line.
The company’s performance is likely to have been supported by efforts to generate new business revenues from its innovative growth model. Its innovation and market development initiatives are expected to have aided sales volumes in the quarter.
Eastman Chemical's performance is likely to have been hurt by the lingering impacts of customer inventory de-stocking. In the second quarter of 2023, the company saw lackluster demand and customer de-stocking in its consumer durables, building & construction, consumables and agriculture end markets. De-stocking is likely to have had an impact on the company's volumes and top line in the third quarter as well.
The company, in July 2023, reduced its demand growth prediction and now anticipates primary demand in several of its end markets to be flat in the second half compared to the first. It also anticipates that customer de-stocking will continue. EMN expects adjusted earnings per share to be lower in the second half of 2023 than in the first half.
Zacks Model
Our proven model does not conclusively predict an earnings beat for Eastman Chemical this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for Eastman Chemical is -2.59%. This is because the Most Accurate Estimate is currently pegged at $1.41 while the Zacks Consensus Estimate stands at $1.45. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Eastman Chemical currently carries a Zacks Rank #3.
Eastman Chemical Company Price and EPS Surprise
Eastman Chemical Company price-eps-surprise | Eastman Chemical Company Quote
Stocks That Warrant a Look
Here are some companies in the basic materials space you may want to consider, as our model shows these have the right combination of elements to post an earnings beat this quarter:
Kinross Gold Corporation (KGC - Free Report) , slated to release earnings on Nov 8, has an Earnings ESP of +8.70% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks Rank #1 stocks here.
The Zacks Consensus Estimate for earnings for KGC for the third quarter is pegged at 9 cents.
LyondellBasell Industries N.V. (LYB - Free Report) , scheduled to release earnings on Oct 27, has an Earnings ESP of +5.14% and carries a Zacks Rank #3.
The consensus estimate for LYB’s earnings for the third quarter is currently pegged at $1.98.
IAMGOLD Corporation (IAG - Free Report) , which is scheduled to release earnings on Nov 9, has an Earnings ESP of +100.00% and carries a Zacks Rank #1.
The consensus estimate for IAG for the third quarter is currently pegged at a loss of 2 cents.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.